ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
Project Title | Institution / Principal Investigator(s) | Grant Type | Year | State |
---|---|---|---|---|
Targeted Degradation of Proliferative Transcription Factors in Pediatric Cancers | University of California at Santa Cruz / Seth Rubin, PhD | Innovation Grants | 2017 | California |
Targeting Childhood Brain Cancer in a Dish to Catalyze New Therapies | University of California, Davis Medical Center / Paul Knoepfler, PhD | Innovation Grants | 2017 | California |
Role of Protocadherin-9 in Enabling Leukemia Cell Colonization of the CNS | National Jewish Health / Jordan Jacobelli, PhD | Innovation Grants | 2017 | Colorado |
Development of Nanoparticle-Encapsulated Chemo/Radio-Sensitizers for Intrathecal Delivery | Yale School of Medicine / Ranjit S. Bindra, MD/PhD & Mark Saltzman, PhD | Innovation Grants | 2017 | Connecticut |
Genome-Wide 5hmC Profiling of Neuroblastoma Tumors and Patient Cell-Free DNA | University of Chicago / Susan Cohn, MD & Chuan He PhD | Innovation Grants | 2017 | Illinois |
Mechanisms of OTX2 Mediated Chromatin Regulation in Medulloblastoma | Massachusetts General Hospital / Miguel Rivera, MD | Innovation Grants | 2017 | Massachusetts |
Targeting BRD9 in Sarcoma | Dana-Farber Cancer Institute / Scott Armstrong, MD/PhD | Innovation Grants | 2017 | Massachusetts |
3-D Printed Self-fitting Shape Memory Bone Grafts for Smart Pediatric Skeletal Reconstruction | University of Massachusetts Medical School / Jie Song, PhD | Innovation Grants | 2017 | Massachusetts |
Characterization of Novel OTX2-semaphorin Gene Signaling Pathways Regulating the ‘Grow and Go’ Arms of Highly Aggressive Medulloblastomas | University of Manitoba / Tamra Werbowetski-Ogilvie, PhD | Innovation Grants | 2017 | Manitoba |
Novel Approaches for Epigenetic Therapy for Relapsed Acute Lymphoblastic Leukemia | The Johns Hopkins University School of Medicine / Linda Resar, MD & Andrei Thomas-Tikhonenko, PhD | Innovation Grants | 2017 | Maryland |
Development of Mithramycin Analogs for Ewing sarcoma | Van Andel Research Institute / Patrick Grohar, MD/PhD | Innovation Grants | 2017 | Michigan |
Long Non-Coding RNAs as Novel Biomarkers and Therapeutic Targets in Pediatric Leukemia | New York University School of Medicine / Iannis Aifantis, PhD | Innovation Grants | 2017 | New York |
De-escalation of Radiotherapy for Medulloblastoma by a Novel DNA Damage Checkpoint Inhibitor | Feinstein Institute for Medical Research - North Shore / Marc Symons, PhD | Innovation Grants | 2017 | New York |
Targeting Metabolic Vulnerabilities in ETP-ALL | Columbia University / Adolfo A. Ferrando, MD/PhD | Innovation Grants | 2017 | New York |
Targeting Pediatric Brain Tumors Using PTPmu Nanochains with Radiofrequency-Releasable Therapeutics | Case Western Reserve University / Susann Brady-Kalnay, PhD & Efstathios Karathanasis, PhD | Innovation Grants | 2017 | Ohio |
Predictive Modeling of MDS Disease Progression From Inherited Bone Marrow Failure Syndrome Using Novel Branching Process and Next Generation Sequencing to Improve Patient-Specific Survival | Cleveland Clinic Foundation / Seth Corey, MD & Marek Kimmel, PhD | Innovation Grants | 2017 | Ohio |
Defining the Cell Surface Landscape of Diagnostic and Relapsed Neuroblastoma: Immunotherapeutic Target Identification | Children’s Hospital of Philadelphia / Sharon Diskin, PhD | Innovation Grants | 2017 | Pennsylvania |
Alternative Splicing in the Pathogenesis of Acute Lymphoblastic Leukemia | Children’s Hospital of Philadelphia / Andrei Thomas-Tikhonenko, PhD | Innovation Grants | 2017 | Pennsylvania |
Establishing the Function of Novel MicroRNAs Associated with Resistance and Relapse in Pediatric AML | Fred Hutchinson Cancer Research Center / Vivian Oehler, MD & Soheil Meshinchi, MD/PhD | Innovation Grants | 2017 | Washington |